Ontology highlight
ABSTRACT: Background
Amyotrophic lateral sclerosis (ALS) is a highly progressive and debilitating neurodegenerative disease, which usually leads to the death of affected individuals within a few years after the onset of symptoms. ALS is currently incurable and very little is known about its pathophysiology. Finding validated biomarkers will help us to advance our understanding of ALS etiology and find better strategies for early diagnosis and management of the disease. The main aim of the present systematic review is to evaluate the concentration of 11 frequently reported biomarkers for ALS in peripheral blood and CSF of patients diagnosed with ALS compared with controls.Methods
This systematic review protocol has been established according to the Preferred Reporting Items for System
SUBMITTER: Agah E
PROVIDER: S-EPMC6300914 | biostudies-literature | 2018 Dec
REPOSITORIES: biostudies-literature